在结直肠癌中免疫治疗反应的预测因素
Jaime González-Montero1,2, Carlos I Rojas1, Mauricio Burotto1
1Bradford Hill Clinical Research Center, Santiago 8420383, Chile.
The oncologist
|June 26, 2024
概括
结肠直肠癌 (CRC) 研究揭示了超越dMMR和MSI的新生物标志物. 识别免疫原性特征是提高更多患者免疫疗法的有效性的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 结肠直肠癌 (CRC) 仍然是全球癌症死亡的主要原因.
- 目前的向疗法 (KRAS,NRAS,BRAF) 和免疫疗法 (免疫检查点封锁) 对有限的患者子组有益.
- 现有的生物标志物,如缺陷不匹配修复 (dMMR) 和微卫星不稳定性 (MSI),并不能捕捉所有响应的患者.
研究的目的:
- 探索用于预测结直肠癌免疫治疗反应的新生物标志物.
- 为了研究CRC的免疫潜力,超出已确定的标记.
- 确定可以从扩展免疫疗法策略中受益的患者子组.
主要方法:
- 对瘤微环境特征的分析.
- 对基因组标记物和肠道微生物群组成的评估.
- 应用共识分子亚型 (CMS) 分类系统.
主要成果:
- 最近的研究表明,CRC不是免疫无效的,可识别的子集表现出高免疫性.
- 新型生物标志物正在瘤微环境,基因组学和肠道微生物群中进行探索.
- 达成共识的分子亚型分类有助于识别免疫性CRC配置文件.
结论:
- 超越像dMMR和MSI这样的单个生物标志物对于推进CRC免疫疗法至关重要.
- 对结直肠癌免疫学领域的全面了解至关重要.
- 开发更有效和个性化的CRC疗法需要综合生物标志物方法.
相关概念视频
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
Cancer Vaccines
351
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
351
Cytotoxic T Cells-mediated Immune Response
888
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
888


